August 2026
1. APOSTOLOU A, Simfukwe R, Saint A, Mushani B, et al
   Adherence to medications, lifestyle advice, and self-monitoring for type 2 diabetes and hypertension in sub-Saharan Africa: A systematic review, meta-analysis, and interactive network analysis.
   PLoS Med. 2026;23:e1005189.
   

   >> Share

   
   July 2026
2. MANYARA AM, Abdullah S, Balshaf A, Manyanga T, et al
   Hypertension and diabetes prevalence, associated factors, care cascade, and quality of life in older adults: A cross-sectional population-based study in The Gambia, South Africa, and Zimbabwe.
   PLoS Med. 2026;23:e1004785.
   

   >> Share

   
   
3. 
   Correction: Plasma proteomic signatures of early retinal neurodegeneration in diabetes: a multi-cohort study.
   PLoS Med. 2026;23:e1005180.
   

   >> Share

   
   June 2026
4. LI H, Zhu Z, Yang S, Cheng W, et al
   Proteomic signatures of early retinal neurodegeneration in type 2 diabetes mellitus.
   PLoS Med. 2026;23:e1004868.
   

   >> Share

   
   
5. CHAN L, Xu W, Chan EWY, Wan EYF, et al
   Cardiovascular outcomes and safety associated with statin therapy for primary prevention in older adults with type 2 diabetes: A target trial emulation study.
   PLoS Med. 2026;23:e1005136.
   

   >> Share

   
   May 2026
6. CHRZANOWSKI J, Walicka M, Burzynski J, Zaras M, et al
   Semaglutide-associated risk of nonarteritic anterior ischemic optic neuropathy in patients with type 2 diabetes: A systematic review and meta-analysis of observational studies.
   PLoS Med. 2026;23:e1005064.
   

   >> Share

   
   April 2026
7. ROUT M, Aston CE, Duggirala R, Goring HH, et al
   Identification of lipid quantitative trait loci linked with cardiometabolic disease in Asian Indians and Europeans: A genome-wide association study and mendelian randomization.
   PLoS Med. 2026;23:e1005039.
   

   >> Share

   
   March 2026
8. SHAO SC, Tsai DH, Chuang AT, Liu KH, et al
   SGLT2 inhibitors, GLP-1 RAs, and DPP4 inhibitors and the risk of hypomagnesemia in type 2 diabetes: A target trial emulation.
   PLoS Med. 2026;23:e1004968.
   

   >> Share

   
   February 2026
9. DOUGLAS LJ, Gamble GD, Harding JE, Samuel D, et al
   Mother and child health 4.5 years after gestational diabetes mellitus managed using tight or less tight targets for glycaemic control: Post-hoc follow-up study of the TARGET trial.
   PLoS Med. 2026;23:e1004635.
   

   >> Share

   
   November 2025
10. SYDNEY GI, Perdigoto AL, Herold KC
    Towards insulin independence in type 1 diabetes: Prospects for prevention and cure.
    PLoS Med. 2025;22:e1004813.
    

    >> Share

    
    September 2025
11. SOWAH SA, Imamura F, Ibsen DB, Monsivais P, et al
    The association of the planetary health diet with type 2 diabetes incidence and greenhouse gas emissions: Findings from the EPIC-Norfolk prospective cohort study.
    PLoS Med. 2025;22:e1004633.
    

    >> Share

    
    
12. WANG L, Tang C, Cheng M, Hao Y, et al
    Association between lower fasting plasma glucose levels during oral glucose tolerance test and adverse perinatal outcomes: A Chinese cohort study.
    PLoS Med. 2025;22:e1004722.
    

    >> Share

    
    May 2025
13. FERALDI A, Zarulli V, Buse K, Hawkes S, et al
    Sex-disaggregated data along the gendered health pathways: A review and analysis of global data on hypertension, diabetes, HIV, and AIDS.
    PLoS Med. 2025;22:e1004592.
    

    >> Share

    
    April 2025
14. WIGHTMAN H, Butterly E, Wei L, McChrystal R, et al
    Frailty in randomized controlled trials of glucose-lowering therapies for type 2 diabetes: An individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse events.
    PLoS Med. 2025;22:e1004553.
    

    >> Share

    
    
15. PAYEN DE LA GARANDERIE M, Hasenbohler A, Dechamp N, Javaux G, et al
    Food additive mixtures and type 2 diabetes incidence: Results from the NutriNet-Sante prospective cohort.
    PLoS Med. 2025;22:e1004570.
    

    >> Share

    
    
16. 
    Reduced insulin use and diabetes complications upon introduction of SGLT-2 inhibitors and GLP1-receptor agonists in low- and middle-income countries: A microsimulation.
    PLoS Med. 2025;22:e1004559.
    

    >> Share

    
    September 2024
17. CALDERWOOD CJ, Marambire ET, Larsson L, Banze D, et al
    HIV, malnutrition, and noncommunicable disease epidemics among tuberculosis-affected households in east and southern Africa: A cross-sectional analysis of the ERASE-TB cohort.
    PLoS Med. 2024;21:e1004452.
    

    >> Share

    
    July 2024
18. DE BRUN M, Magnuson A, Montgomery S, Patil S, et al
    Changing diagnostic criteria for gestational diabetes (CDC4G) in Sweden: A stepped wedge cluster randomised trial.
    PLoS Med. 2024;21:e1004420.
    

    >> Share

    
    
19. QIAN X, Wang J, Gong Q, An Y, et al
    Non-diabetes status after diagnosis of impaired glucose tolerance and risk of long-term death and vascular complications: A post hoc analysis of the Da Qing Diabetes Prevention Outcome Study.
    PLoS Med. 2024;21:e1004419.
    

    >> Share

    
    June 2024
20. ALI MK, Singh K, Kondal D, Devarajan R, et al
    Effect of a multicomponent quality improvement strategy on sustained achievement of diabetes care goals and macrovascular and microvascular complications in South Asia at 6.5 years follow-up: Post hoc analyses of the CARRS randomized clinical trial.
    PLoS Med. 2024;21:e1004335.
    

    >> Share

    
    April 2024
21. SHI M, Yang A, Lau ESH, Luk AOY, et al
    A novel electronic health record-based, machine-learning model to predict severe hypoglycemia leading to hospitalizations in older adults with diabetes: A territory-wide cohort and modeling study.
    PLoS Med. 2024;21:e1004369.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share